Group | Anti-TB drugs |
1) First-line oral anti-TB drugs | Isoniazid (H) Rifampicin (R) Ethambutol (E) Pyrazinamide (Z) Rifabutin (Rfb) Rifapentine (Rpt) |
2) Injectable anti-TB drugs (injectable or parenteral agents) | Streptomycin (S) Kanamycin (Km) Amikacin (Am) Capreomycin (Cm) |
3) Fluoroquinolones (FQs) | Levofloxacin (Lfx) Moxifloxacin (Mfx) Gatifloxacin (Gfx) Ofloxacin (Ofx) |
4) Oral bacteriostatic second-line anti-TB drugs | Ethionamide (Eto) Prothionamide (Pto) Cycloserine (Cs) Terizidone (Trd) p-Aminosalicylic acid (PAS) p-Aminosalicylate sodium (PAS-Na) |
5) Anti-TB drugs with limited data on efficacy and/or long-term safety in the treatment of drug-resistant TB | Bedaquiline (Bdq) Delamanid (Dlm) Linezolid (Lzd) Clofazimine (Cfz) Amoxicillin/clavulanate (Amx/Clv) Imipenem/cilastatin (Ipm/Cln) Meropenem (Mpm) High-dose isoniazid (high-dose H) Thioacetazone (T) Clarithromycin (Clr) |
TB: tuberculosis. Reproduced and modified from [19] with permission from the publisher.